Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Other Accumulated Expenses (2016 - 2017)

Tenax Therapeutics' Other Accumulated Expenses history spans 5 years, with the latest figure at $3.5 million for Q1 2017.

  • For Q1 2017, Other Accumulated Expenses fell 6.45% year-over-year to $3.5 million; the TTM value through Mar 2017 reached $3.5 million, down 6.45%, while the annual FY2016 figure was $4.4 million, N/A changed from the prior year.
  • Other Accumulated Expenses for Q1 2017 was $3.5 million at Tenax Therapeutics, down from $4.4 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $4.4 million in Q4 2016 and bottomed at $16715.0 in Q3 2013.
  • The 5-year median for Other Accumulated Expenses is $1.8 million (2015), against an average of $1.9 million.
  • The largest annual shift saw Other Accumulated Expenses surged 2579.82% in 2015 before it dropped 6.45% in 2017.
  • A 5-year view of Other Accumulated Expenses shows it stood at $103666.0 in 2013, then soared by 724.3% to $854518.0 in 2014, then soared by 199.48% to $2.6 million in 2015, then skyrocketed by 70.43% to $4.4 million in 2016, then decreased by 19.49% to $3.5 million in 2017.
  • Per Business Quant, the three most recent readings for TENX's Other Accumulated Expenses are $3.5 million (Q1 2017), $4.4 million (Q4 2016), and $3.3 million (Q3 2016).